Free Trial
NASDAQ:DRIO

DarioHealth (DRIO) Stock Price, News & Analysis

DarioHealth logo
$0.72 0.00 (-0.36%)
Closing price 03:59 PM Eastern
Extended Trading
$0.72 0.00 (-0.33%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About DarioHealth Stock (NASDAQ:DRIO)

Key Stats

Today's Range
$0.71
$0.74
50-Day Range
$0.66
$0.76
52-Week Range
$0.50
$1.55
Volume
184,567 shs
Average Volume
285,569 shs
Market Capitalization
$31.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00
Consensus Rating
Moderate Buy

Company Overview

DarioHealth Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
27th Percentile Overall Score

DRIO MarketRank™: 

DarioHealth scored higher than 27% of companies evaluated by MarketBeat, and ranked 797th out of 920 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    DarioHealth has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    DarioHealth has only been the subject of 1 research reports in the past 90 days.

  • Read more about DarioHealth's stock forecast and price target.
  • Earnings Growth

    Earnings for DarioHealth are expected to grow in the coming year, from ($1.18) to ($1.06) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of DarioHealth is -1.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of DarioHealth is -1.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    DarioHealth has a P/B Ratio of 0.34. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about DarioHealth's valuation and earnings.
  • Percentage of Shares Shorted

    7.50% of the float of DarioHealth has been sold short.
  • Short Interest Ratio / Days to Cover

    DarioHealth has a short interest ratio ("days to cover") of 13.9, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in DarioHealth has recently increased by 2.07%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    DarioHealth does not currently pay a dividend.

  • Dividend Growth

    DarioHealth does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.50% of the float of DarioHealth has been sold short.
  • Short Interest Ratio / Days to Cover

    DarioHealth has a short interest ratio ("days to cover") of 13.9, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in DarioHealth has recently increased by 2.07%, indicating that investor sentiment is decreasing.
  • Search Interest

    1 people have searched for DRIO on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, DarioHealth insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    11.20% of the stock of DarioHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 33.39% of the stock of DarioHealth is held by institutions.

  • Read more about DarioHealth's insider trading history.
Receive DRIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DarioHealth and its competitors with MarketBeat's FREE daily newsletter.

DRIO Stock News Headlines

$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
See More Headlines

DRIO Stock Analysis - Frequently Asked Questions

DarioHealth's stock was trading at $0.7861 at the start of the year. Since then, DRIO stock has decreased by 9.8% and is now trading at $0.7090.

DarioHealth Corp. (NASDAQ:DRIO) released its earnings results on Wednesday, May, 14th. The company reported ($0.14) EPS for the quarter, missing the consensus estimate of ($0.07) by $0.07. The company had revenue of $6.75 million for the quarter, compared to the consensus estimate of $7.48 million. DarioHealth had a negative trailing twelve-month return on equity of 65.81% and a negative net margin of 159.80%.
Read the conference call transcript
.

DarioHealth subsidiaries include these companies: PsyInnovations Inc., Upright Technologies Ltd., Labstyle Innovation Ltd., PsyInnovations India Private Limited., and Upright Technologies Inc..

Shares of DRIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that DarioHealth investors own include NVIDIA (NVDA), Meta Platforms (META), Pfizer (PFE), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM) and Tesla (TSLA).

Company Calendar

Last Earnings
5/14/2025
Today
7/10/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:DRIO
CIK
1533998
Employees
200
Year Founded
2011

Price Target and Rating

High Price Target
$3.00
Low Price Target
$1.00
Potential Upside/Downside
+178.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$42.75 million
Net Margins
-159.80%
Pretax Margin
-159.22%

Debt

Sales & Book Value

Annual Sales
$27.04 million
Price / Cash Flow
N/A
Book Value
$2.11 per share
Price / Book
0.34

Miscellaneous

Free Float
39,484,000
Market Cap
$31.90 million
Optionable
Optionable
Beta
1.55

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:DRIO) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners